Read Time: 3 minutes
An examination of the SCALE-UP Counts program was recently published in the journal . This analysis, led by Yelena Wu, PhD, investigator at Huntsman Cancer Institute and associate professor in the department of dermatology at the (the U), and , investigator at Huntsman Cancer Institute and professor in the department of population health sciences at the U, received support from (RADx-UP) and funding from the (NIH),
The SCALE-UP Counts program was designed to promote COVID-19 testing through collaboration with local schools, especially those who serve historically marginalized populations. This was done using two-way texting, meaning that staff, parents, or guardians could respond. Scale Up COUNTS sought to make it easier for schools to have access to COVID-19 testing and provided guidance to families and staff on when to test.
Wu鈥檚 research is typically focused on cancer prevention in children, teens, and young adults. However, during the pandemic, along with Wetter, Adam Hersh, MD, PhD, , , , and , she used her expertise to advise local K-12 schools on COVID-19 testing policies and logistics.
, visiting instructor at Huntsman Cancer Institute, helped lead a , which described initial findings from the Scale Up COUNTS study. Results from the analysis of the SCALE-UP Counts program, and the accompanying piece led by Stump, show that texting can increase participation in public health programs.
鈥淭ext messaging and health navigation are feasible ways to reach staff in K-12 schools to provide health screening messages,鈥 says Stump. 鈥淲e found that 99% of staff had a valid cell phone number for the program, and fewer than 4% chose to opt out of the program. At the time of these analyses, four months after the program started, 19% of staff had engaged with the SCALE-UP Counts system in some way.鈥
These results not only show that the program helped schools and families navigate the pandemic, but can help researchers understand how to increase participation in cancer prevention, screening, and education initiatives in the future.
鈥淲e wanted to see if the use of readily available technology increased the participation of the public in health programs,鈥 says Wu. 鈥淐OVID-19 was a unique opportunity to test this while providing what we thought was an important service to our communities in Utah."
Wu鈥檚 team will continue to evaluate the reach and engagement of the SCALE-UP program, as well as the cost-effectiveness of using texting to communicate health information to large groups of people.
鈥淭ext messaging seems to be an effective, and low-resource opportunity to meet people where they are at,鈥 says Stump. 鈥淭his is important when looking into how we can make public health initiatives more accessible.鈥
In addition to funding from ABC Science Collaborative, and RAD-x UP, this study was supported by the NCI including P30 CA042014 and Huntsman Cancer Foundation.
Media Contact
Heather Simonsen
Public Affairs Senior Manager
Huntsman Cancer Institute
801 581-3194
public.affairs@hci.utah.edu
About Huntsman Cancer Institute at the University of Utah
Huntsman Cancer Institute at the is the National Cancer Institute-designated Comprehensive Cancer Center for Utah, Idaho, Montana, Nevada, and Wyoming. With a legacy of innovative cancer research, groundbreaking discoveries, and world-class patient care, we are transforming the way cancer is understood, prevented, diagnosed, treated, and survived. Huntsman Cancer Institute focuses on delivering the most advanced cancer healing and prevention through scientific breakthroughs and cutting-edge technology to advance cancer treatments of the future beyond the standard of care today. We have more than 300 open clinical trials and 250 research teams studying cancer. More genes for inherited cancers have been discovered at Huntsman Cancer Institute than at any other cancer center. Our scientists are world-renowned for understanding how cancer begins and using that knowledge to develop innovative approaches to treat each patient鈥檚 unique disease. Huntsman Cancer Institute was founded by Jon M. and Karen Huntsman.